USING ONLY THE BEST TECHNOLOGY POSSIBLE
The test uses an innovative, comprehensive, and clinically applicable stool profile, utilizing multiplex PCR molecular technology together with growth-based culture and ID by MALDI-TOF, sensitive biochemical assays, and microscopy to detect and assess the status of pathogens, viruses, parasites, and bacteria that may be contributing to acute or chronic gastrointestinal symptoms and disease.
Microbiome Abundance and Diversity The GI360™ Profile is a gut microbiota DNA analysis tool that identifies and characterizes the abundance and diversity of more than 45 targeted analytes that peer-reviewed research has shown to contribute to dysbiosis and other chronic disease states.
The GI360™ can also identify the presence of pathogenic viruses, bacteria, and parasites using multiplexed, real-time PCR.
The Dysbiosis Index (DI) is a calculation with scores from 1 to 5 based on the overall bacterial abundance and profile within the patient’s sample as compared to a reference population. Values above 2 indicate a microbiota profile that differs from the defined normobiotic reference population (i.e., dysbiosis). The higher the DI above 2, the more the sample is considered to deviate from normobiosis.
OTHER HELPFUL INFORMATION FOR YOUR PATIENTS
- Specimen: Stool
- Turnaround time: Three to four weeks